Pharmaceutical CEOs set to Testify in Congress on February 26th
Drug pricing continues to be a hot topic in congress. It was brought up during this week’s State of the Union address and congress members recently sent requests to Merck, Pfizer, Sanofi, Bristol-Myers Squibb AbbVie, AstraZeneca and Johnson & Johnson to testify before the Senate Finance committee. Merck, Pfizer, Sanofi and Bristol-Myers Squibb have agreed. For more information follow this link to the full story on FiercePharma.
Adapting to Your Needs
Whether you are seeking specific talent or unique opportunities, we provide an established level of service that is receptive and responsive to your needs. Connect with us to learn how we can best serve you.